🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/08/2023 | 68,54 | 68,82 | 67,00 | 67,22 | -2,20% | 2,66% | 65.300 |
| 10/08/2023 | 70,85 | 70,88 | 68,65 | 68,73 | -2,81% | 3,15% | 138.600 |
| 09/08/2023 | 67,13 | 70,84 | 65,96 | 70,72 | +5,35% | 7,27% | 170.700 |
| 08/08/2023 | 66,14 | 67,61 | 65,60 | 67,13 | +1,25% | 3,04% | 130.800 |
| 07/08/2023 | 66,85 | 67,78 | 65,59 | 66,30 | -0,73% | 3,28% | 117.000 |
| 04/08/2023 | 66,52 | 68,01 | 66,52 | 66,79 | +0,51% | 2,24% | 94.300 |
| 03/08/2023 | 65,89 | 67,00 | 65,41 | 66,45 | +0,36% | 2,41% | 70.800 |
| 02/08/2023 | 66,20 | 66,52 | 65,57 | 66,21 | -0,73% | 1,44% | 55.900 |
| 01/08/2023 | 66,80 | 67,31 | 65,78 | 66,70 | -0,34% | 2,29% | 63.600 |
| 31/07/2023 | 68,01 | 68,01 | 66,50 | 66,93 | -1,59% | 2,22% | 97.000 |
| 28/07/2023 | 67,82 | 68,25 | 67,42 | 68,01 | +0,85% | 1,22% | 57.800 |
| 27/07/2023 | 68,18 | 68,61 | 66,84 | 67,44 | -0,41% | 2,60% | 64.000 |
| 26/07/2023 | 67,21 | 67,83 | 66,88 | 67,72 | +0,62% | 1,41% | 55.800 |
| 25/07/2023 | 66,34 | 68,33 | 66,34 | 67,30 | +1,11% | 3,00% | 70.200 |
| 24/07/2023 | 67,36 | 68,10 | 66,12 | 66,56 | -1,35% | 2,94% | 96.100 |
| 21/07/2023 | 67,81 | 68,19 | 67,09 | 67,47 | -0,15% | 1,62% | 74.400 |
| 20/07/2023 | 67,71 | 68,00 | 67,36 | 67,57 | -0,06% | 0,95% | 52.900 |
| 19/07/2023 | 68,11 | 68,63 | 67,32 | 67,61 | -0,76% | 1,92% | 81.300 |
| 18/07/2023 | 68,76 | 69,98 | 67,56 | 68,13 | -0,92% | 3,52% | 72.700 |
| 17/07/2023 | 68,49 | 69,68 | 67,54 | 68,76 | +1,34% | 3,12% | 159.600 |
| 14/07/2023 | 68,51 | 68,85 | 66,36 | 67,85 | -0,91% | 3,63% | 137.800 |
| 13/07/2023 | 69,01 | 70,01 | 68,31 | 68,47 | -0,55% | 2,46% | 111.900 |
| 12/07/2023 | 70,84 | 71,15 | 68,74 | 68,85 | -0,92% | 3,40% | 91.400 |
| 11/07/2023 | 70,30 | 70,64 | 68,31 | 69,49 | -0,52% | 3,31% | 85.800 |
| 10/07/2023 | 69,74 | 71,50 | 69,55 | 69,85 | +0,29% | 2,80% | 79.100 |
| 07/07/2023 | 70,09 | 71,00 | 69,56 | 69,65 | -0,37% | 2,05% | 113.700 |
| 06/07/2023 | 70,90 | 70,90 | 69,16 | 69,91 | -2,20% | 2,45% | 67.600 |
| 05/07/2023 | 72,49 | 72,49 | 71,10 | 71,48 | -1,64% | 1,92% | 88.400 |
| 03/07/2023 | 72,15 | 72,97 | 71,51 | 72,67 | +0,79% | 2,02% | 25.100 |
| 30/06/2023 | 73,07 | 73,85 | 72,01 | 72,10 | -0,69% | 2,52% | 87.400 |